VIP induced alloantigen-specific human regulatory T-cells that could prevent transplant rejection, advancing neuropeptide-based tolerance induction for organ transplantation.
Key findingVIP induced alloantigen-specific human regulatory T-cells that could prevent transplant rejection, advancing neuropeptide-based tolerance induction fo
What the researchers found
VIP induced alloantigen-specific human regulatory T-cells that could prevent transplant rejection, advancing neuropeptide-based tolerance induction for organ transplantation.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
Journal of immunology (Baltimore, Md. : 1950), 183(7), 4346-59
Citation
Pozo, David; Anderson, Per; Gonzalez-Rey, Elena. (2009). Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.. Journal of immunology (Baltimore, Md. : 1950), 183(7), 4346-59. https://doi.org/10.4049/jimmunol.0900400